首页 > 最新文献

Journal of Surgical Research最新文献

英文 中文
Heart Transplant Centers With and Without Liver Transplant Programs: Analysis of Scientific Registry of Transplant Recipients Metrics. 有和没有肝移植项目的心脏移植中心:移植受者指标的科学登记分析。
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-14 DOI: 10.1016/j.jss.2024.11.015
Faizaan Siddique, Sanath Patil, Keshava Rajagopal, John W Entwistle, Rohinton J Morris, Adam Bodzin, Vakhtang Tchantchaleishvili

Introduction: We studied the relationship between heart transplant centers with and without liver transplant programs regarding volume, waitlist duration, waitlist survival, and 1-y posttransplant survival.

Methods: Scientific Registry of Transplant Recipients data were acquired in July 2023 and represented transplant centers with adult organ transplant volumes in the United States over the past year. This system involved a five-tier ranking system from one to five, where tier one programs had the lowest rating and tier five programs had the highest rating.

Results: Among heart transplant centers, there were 37 (29.6%) heart-only centers and 88 (70.4%) heart-liver centers. Median heart transplant volume was greater in heart-liver centers (28 [interquartile range: 18-47]) relative to heart-only centers (10 [2-20]; P < 0.001). Median heart waitlist duration rating was higher among heart-liver centers (3 [2-4] versus 2 [2-3]; P = 0.05). A higher waitlist duration rating was associated with greater annual transplant volume (P < 0.001). Waitlist survival rating distributions were similar across heart-only and heart-liver centers (3 [2-4] versus 4 [2-4]; P = 0.33). No significant association was observed between heart transplant volume and waitlist survival rating (P = 0.52). Median posttransplant survival rating between the two transplant center types was also comparable (3 [2-4] versus 3 [2-4]; P = 0.43). A higher posttransplant survival rating was associated with higher transplant volume (P < 0.05).

Conclusions: Heart transplant centers with concomitant liver transplant programs have a superior waitlist duration rating as well as higher overall transplant volumes when compared with heart-only transplant centers.

简介我们研究了有肝脏移植项目和没有肝脏移植项目的心脏移植中心之间在移植量、等待时间、等待者存活率和移植后1年存活率方面的关系:移植受者科学注册中心的数据于2023年7月获得,代表了过去一年美国成人器官移植量的移植中心。该系统采用五级排名制,从一级到五级,一级项目评级最低,五级项目评级最高:在心脏移植中心中,有 37 家(29.6%)纯心脏移植中心和 88 家(70.4%)心肝移植中心。心肝中心的心脏移植量中位数(28[四分位距:18-47])高于纯心脏中心(10[2-20];P 结论:心肝中心的心脏移植量中位数高于纯心脏中心(28[四分位距:18-47]):与纯心脏移植中心相比,同时开展肝脏移植项目的心脏移植中心的候选名单持续时间更长,总移植量也更大。
{"title":"Heart Transplant Centers With and Without Liver Transplant Programs: Analysis of Scientific Registry of Transplant Recipients Metrics.","authors":"Faizaan Siddique, Sanath Patil, Keshava Rajagopal, John W Entwistle, Rohinton J Morris, Adam Bodzin, Vakhtang Tchantchaleishvili","doi":"10.1016/j.jss.2024.11.015","DOIUrl":"10.1016/j.jss.2024.11.015","url":null,"abstract":"<p><strong>Introduction: </strong>We studied the relationship between heart transplant centers with and without liver transplant programs regarding volume, waitlist duration, waitlist survival, and 1-y posttransplant survival.</p><p><strong>Methods: </strong>Scientific Registry of Transplant Recipients data were acquired in July 2023 and represented transplant centers with adult organ transplant volumes in the United States over the past year. This system involved a five-tier ranking system from one to five, where tier one programs had the lowest rating and tier five programs had the highest rating.</p><p><strong>Results: </strong>Among heart transplant centers, there were 37 (29.6%) heart-only centers and 88 (70.4%) heart-liver centers. Median heart transplant volume was greater in heart-liver centers (28 [interquartile range: 18-47]) relative to heart-only centers (10 [2-20]; P < 0.001). Median heart waitlist duration rating was higher among heart-liver centers (3 [2-4] versus 2 [2-3]; P = 0.05). A higher waitlist duration rating was associated with greater annual transplant volume (P < 0.001). Waitlist survival rating distributions were similar across heart-only and heart-liver centers (3 [2-4] versus 4 [2-4]; P = 0.33). No significant association was observed between heart transplant volume and waitlist survival rating (P = 0.52). Median posttransplant survival rating between the two transplant center types was also comparable (3 [2-4] versus 3 [2-4]; P = 0.43). A higher posttransplant survival rating was associated with higher transplant volume (P < 0.05).</p><p><strong>Conclusions: </strong>Heart transplant centers with concomitant liver transplant programs have a superior waitlist duration rating as well as higher overall transplant volumes when compared with heart-only transplant centers.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"131-135"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142828790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing How Three Frailty Scales Predict Negative Outcomes in Trauma Patients With Rib Fractures. 比较三种虚弱量表如何预测肋骨骨折创伤患者的负面结果。
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-16 DOI: 10.1016/j.jss.2024.11.016
Lawrence R Feng, Colette Galet, Dionne A Skeete

Introduction: Frailty is a risk factor for adverse outcomes after injury. Herein, we compared three frailty scales: the Canadian Study of Health and Aging clinical frailty scale, the rib fracture frailty index (RFFI) and the modified frailty index-5, to assess which scale is most applicable in predicting risk for negative outcomes in older patients with rib fractures.

Methods: Patients ≥65 admitted for rib fractures were retrospectively scored for frailty using the RFFI, Canadian Study of Health and Aging clinical frailty scale, and modified frailty index-5. Outcomes examined were in-hospital mortality, pneumonia, in-hospital intubation, hospital length of stay, and discharge to skilled nursing facilities. Areas under the curve, sensitivity, specificity, negative predictive value, and positive predictive value were determined for each frailty scale with each outcome. Agreement was determined using Fleiss' Kappa. P <0.05 was considered significant.

Results: Three hundred forty-one patients were included. All three scales demonstrated similar predictive abilities for the measured outcomes. RFFI predicted mortality and pneumonia 70% of the time. All three scales predicted discharge to skilled nursing facilities 60% of the time. The concordance for all three frailty scales was 241/341 (70.7%). Fleiss Kappa was 0.40 [0.34-0.46] (P < 0.001), indicating a fair to moderate agreement. The predictive ability of all three scales was higher in patients 65-74 y old than in patients ≥75.

Conclusions: Overall, no scale appeared to significantly outperform the others by areas under the curve estimation. Interrater reliability was higher in the 65 to 74-y-old population compared to the 75 and older population.

简介:虚弱是损伤后不良后果的危险因素。在此,我们比较了三种虚弱量表:加拿大健康与老龄化研究临床虚弱量表、肋骨骨折虚弱指数(RFFI)和修改后的虚弱指数-5,以评估哪种量表最适用于预测老年肋骨骨折患者的不良结局风险。方法:采用RFFI、加拿大健康与老龄化研究临床虚弱量表和改良的虚弱指数-5对≥65岁的肋骨骨折患者进行回顾性评分。检查的结果是住院死亡率、肺炎、住院插管、住院时间和出院到熟练护理机构。对每个虚弱量表的每个结果确定曲线下面积、敏感性、特异性、阴性预测值和阳性预测值。使用Fleiss的Kappa确定协议。结果:共纳入341例患者。所有三个量表对测量结果的预测能力相似。RFFI预测死亡率和肺炎的准确率为70%。所有三个量表预测出院到熟练护理机构的时间为60%。三个虚弱量表的一致性为241/341(70.7%)。Fleiss Kappa为0.40 [0.34-0.46](P)结论:总体而言,没有量表在曲线下估计面积上明显优于其他量表。与75岁及以上的人群相比,65岁至74岁人群的互估者可靠性更高。
{"title":"Comparing How Three Frailty Scales Predict Negative Outcomes in Trauma Patients With Rib Fractures.","authors":"Lawrence R Feng, Colette Galet, Dionne A Skeete","doi":"10.1016/j.jss.2024.11.016","DOIUrl":"10.1016/j.jss.2024.11.016","url":null,"abstract":"<p><strong>Introduction: </strong>Frailty is a risk factor for adverse outcomes after injury. Herein, we compared three frailty scales: the Canadian Study of Health and Aging clinical frailty scale, the rib fracture frailty index (RFFI) and the modified frailty index-5, to assess which scale is most applicable in predicting risk for negative outcomes in older patients with rib fractures.</p><p><strong>Methods: </strong>Patients ≥65 admitted for rib fractures were retrospectively scored for frailty using the RFFI, Canadian Study of Health and Aging clinical frailty scale, and modified frailty index-5. Outcomes examined were in-hospital mortality, pneumonia, in-hospital intubation, hospital length of stay, and discharge to skilled nursing facilities. Areas under the curve, sensitivity, specificity, negative predictive value, and positive predictive value were determined for each frailty scale with each outcome. Agreement was determined using Fleiss' Kappa. P <0.05 was considered significant.</p><p><strong>Results: </strong>Three hundred forty-one patients were included. All three scales demonstrated similar predictive abilities for the measured outcomes. RFFI predicted mortality and pneumonia 70% of the time. All three scales predicted discharge to skilled nursing facilities 60% of the time. The concordance for all three frailty scales was 241/341 (70.7%). Fleiss Kappa was 0.40 [0.34-0.46] (P < 0.001), indicating a fair to moderate agreement. The predictive ability of all three scales was higher in patients 65-74 y old than in patients ≥75.</p><p><strong>Conclusions: </strong>Overall, no scale appeared to significantly outperform the others by areas under the curve estimation. Interrater reliability was higher in the 65 to 74-y-old population compared to the 75 and older population.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"136-144"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142846869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Major Perioperative Bleeding in Patients on Dialysis Undergoing Nonelective Abdominal Surgeries. 非选择性腹部手术透析患者围手术期大出血。
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-28 DOI: 10.1016/j.jss.2024.11.029
Joy Zhou Done, Claire A Ostertag-Hill, Olivia Ziegler, Sivamainthan Vithiananthan

Introduction: Patients with end-stage renal disease (ESRD) are at increased risk for bleeding complications following surgery. However, the approach to the preoperative risk assessment and risk reduction, if feasible, in ESRD patients undergoing nonelective abdominal surgery has not been comprehensively studied. We aim to determine the prevalence and risk factors for perioperative bleeding in patients on dialysis undergoing nonelective abdominal surgery.

Methods: Using the American College of Surgeons National Surgical Quality Improvement Program 2005-2017 database, we identified patients on dialysis who underwent a variety of nonelective abdominal surgeries by Current Procedural Terminology code. Rates of major perioperative bleeding, defined as bleeding requiring red blood cell transfusion within 72 h after surgery, were calculated and stratified by procedure type. Multivariate logistic regression was used to identify risk factors for major perioperative bleeding. Thirty-day mortality rates were compared between those who had a major perioperative bleed and those who did not.

Results: Of 9102 patients on dialysis undergoing nonelective abdominal surgery, 2793 (30.7%) experienced major perioperative bleeding requiring transfusion and 2002 (22.0%) died within 30 d of surgery. By multivariable logistic regression, patients who were female, independent or partially dependent in activities of daily living, ventilator dependent, had disseminated cancer, or had chronic steroid use at baseline were found to be at elevated risk for major perioperative bleeding. Elevated partial thromboplastin time, blood urea nitrogen, anemia, and hypoalbuminemia were also associated with higher odds of major bleeding. Compared to patients undergoing herniorrhaphy (lowest risk), the odds of major perioperative bleeding were highest for patients undergoing hepatic surgery (odds ratio [OR] = 18.09), splenic surgery (OR = 10.86), and pancreatic surgery (OR = 9.59). Major perioperative bleeding was associated with increased 30-d mortality (34.0% versus 16.7%, P < 0.001).

Conclusions: Patients with ESRD experience high rates of bleeding requiring transfusion following emergent abdominal surgery. Derangements in preoperative laboratories and baseline patient characteristics may be useful in assessing bleeding risk in this patient population.

终末期肾病(ESRD)患者手术后出血并发症的风险增加。然而,对于接受非选择性腹部手术的ESRD患者,术前风险评估和降低风险的方法(如果可行)尚未进行全面的研究。我们的目的是确定非选择性腹部手术透析患者围手术期出血的患病率和危险因素。方法:使用美国外科医师学会国家手术质量改进计划2005-2017数据库,我们根据现行程序术语代码确定了接受各种非选择性腹部手术的透析患者。计算围手术期大出血(定义为术后72小时内需要输血的出血)的发生率,并按手术类型分层。多因素logistic回归分析围手术期大出血的危险因素。比较了围手术期大出血患者和未大出血患者的30天死亡率。结果:9102例非择期腹部手术透析患者中,2793例(30.7%)出现围手术期大出血需要输血,2002例(22.0%)在手术后30 d内死亡。通过多变量logistic回归,发现女性、独立或部分依赖日常生活活动、依赖呼吸机、患有弥散性癌症或基线时长期使用类固醇的患者围手术期大出血的风险较高。升高的部分凝血活酶时间、血尿素氮、贫血和低白蛋白血症也与大出血的高几率相关。与行疝修补术(风险最低)的患者相比,肝手术(优势比[OR] = 18.09)、脾手术(OR = 10.86)和胰腺手术(OR = 9.59)患者围手术期大出血的几率最高。围手术期大出血与30天死亡率增加相关(34.0%对16.7%,P < 0.001)。结论:ESRD患者在急诊腹部手术后需要输血的出血率很高。术前实验室和基线患者特征的差异可能有助于评估该患者群体的出血风险。
{"title":"Major Perioperative Bleeding in Patients on Dialysis Undergoing Nonelective Abdominal Surgeries.","authors":"Joy Zhou Done, Claire A Ostertag-Hill, Olivia Ziegler, Sivamainthan Vithiananthan","doi":"10.1016/j.jss.2024.11.029","DOIUrl":"10.1016/j.jss.2024.11.029","url":null,"abstract":"<p><strong>Introduction: </strong>Patients with end-stage renal disease (ESRD) are at increased risk for bleeding complications following surgery. However, the approach to the preoperative risk assessment and risk reduction, if feasible, in ESRD patients undergoing nonelective abdominal surgery has not been comprehensively studied. We aim to determine the prevalence and risk factors for perioperative bleeding in patients on dialysis undergoing nonelective abdominal surgery.</p><p><strong>Methods: </strong>Using the American College of Surgeons National Surgical Quality Improvement Program 2005-2017 database, we identified patients on dialysis who underwent a variety of nonelective abdominal surgeries by Current Procedural Terminology code. Rates of major perioperative bleeding, defined as bleeding requiring red blood cell transfusion within 72 h after surgery, were calculated and stratified by procedure type. Multivariate logistic regression was used to identify risk factors for major perioperative bleeding. Thirty-day mortality rates were compared between those who had a major perioperative bleed and those who did not.</p><p><strong>Results: </strong>Of 9102 patients on dialysis undergoing nonelective abdominal surgery, 2793 (30.7%) experienced major perioperative bleeding requiring transfusion and 2002 (22.0%) died within 30 d of surgery. By multivariable logistic regression, patients who were female, independent or partially dependent in activities of daily living, ventilator dependent, had disseminated cancer, or had chronic steroid use at baseline were found to be at elevated risk for major perioperative bleeding. Elevated partial thromboplastin time, blood urea nitrogen, anemia, and hypoalbuminemia were also associated with higher odds of major bleeding. Compared to patients undergoing herniorrhaphy (lowest risk), the odds of major perioperative bleeding were highest for patients undergoing hepatic surgery (odds ratio [OR] = 18.09), splenic surgery (OR = 10.86), and pancreatic surgery (OR = 9.59). Major perioperative bleeding was associated with increased 30-d mortality (34.0% versus 16.7%, P < 0.001).</p><p><strong>Conclusions: </strong>Patients with ESRD experience high rates of bleeding requiring transfusion following emergent abdominal surgery. Derangements in preoperative laboratories and baseline patient characteristics may be useful in assessing bleeding risk in this patient population.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"356-366"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Frailty and Preoperative Decision-Making in Rectal Prolapse Repair. 虚弱与直肠脱垂修复术前决策的关系。
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-28 DOI: 10.1016/j.jss.2024.11.038
Charlotte M Rajasingh, Madison S McCarthy, Nicolas B Barreto, Amber W Trickey, Caitlin Bungo, Leila Neshatian, Brooke H Gurland

Introduction: Abdominal and perineal repairs for rectal prolapse are offered to patients based on surgeon assessment of risk. Interpretations of risk can vary. We sought to understand how the preoperative Risk Analysis Index (RAI) score, a validated measure of frailty, aligned with our existing decision-making process for rectal prolapse repair.

Methods: Rectal prolapse repair cases were recorded in an Institutional Review Board approved registry from 2017 to 2022. Abdominal and perineal operations were determined based on an experienced surgeon's recommendation. The preoperative RAI was collected; a score≥30 indicates significant frailty. Preoperative and postoperative characteristics were compared using t-tests and Fisher's exact tests.

Results: About 130 patients underwent abdominal repairs and 51 underwent perineal repairs. Perineal patients were more often frail (abdominal: 9 [7%] versus perineal: 21 [41%], P < 0.001) and had a higher rate of cardiac comorbidities (abdominal: 42 [32%] versus perineal: 35 [69%], P < 0.001). A similar share of patients were undergoing repair for recurrent prolapse (abdominal: n = 29 [22%] versus perineal: n = 11 [22%], P > 0.99). Perineal repair patients were more likely to need assistance with mobility (n = 24 [47%]) and live in a facility (n = 15 [29%]). Patients in both groups recovered well (complication rate abdominal: 28 [22%] versus 11 [22%], P > 0.99) and were satisfied with postoperative outcomes (Patient Global Impression of Change score abdominal: 6 [interquartile range: 6, 7] versus perineal: 6 [5, 7], P = 0.12). Recurrence rates were higher after perineal repair (abdominal: 12 [9%] versus perineal: 20 [39%], P < 0.001).

Conclusions: Most abdominal repair patients were not frail, but many nonfrail patients underwent perineal operations based on surgeon perception of comorbidities. Using the RAI tool may provide an opportunity to guide decision-making around operative approach for rectal prolapse and overcome potential surgeon bias.

简介:腹部和会阴修复直肠脱垂的病人提供基于外科医生的风险评估。对风险的解释各不相同。我们试图了解术前风险分析指数(RAI)评分是如何与我们现有的直肠脱垂修复决策过程相一致的。方法:直肠脱垂修复病例记录在机构审查委员会批准的登记处,从2017年到2022年。腹部和会阴手术是根据经验丰富的外科医生的建议决定的。收集术前RAI;评分≥30表示明显虚弱。采用t检验和Fisher精确检验比较术前和术后特征。结果:腹部修复130例,会阴修复51例。会阴的患者更容易虚弱(腹部:9[7%],会阴:21 [41%],P 0.99)。会阴修复患者更有可能需要活动辅助(n = 24[47%])和住在医疗机构(n = 15[29%])。两组患者均恢复良好(腹部并发症发生率:28例[22%]对11例[22%],P < 0.99),术后结果满意(患者总体印象变化评分:腹部:6[四分位间距:6,7]对会阴:6 [5,7],P = 0.12)。会阴修复术后复发率较高(腹部:12[9%],会阴:20 [39%],P结论:大多数腹部修复患者并不虚弱,但许多非虚弱患者根据外科医生对合并症的看法接受会阴手术。使用RAI工具可以为直肠脱垂手术入路的决策提供指导,并克服潜在的外科医生偏见。
{"title":"Association Between Frailty and Preoperative Decision-Making in Rectal Prolapse Repair.","authors":"Charlotte M Rajasingh, Madison S McCarthy, Nicolas B Barreto, Amber W Trickey, Caitlin Bungo, Leila Neshatian, Brooke H Gurland","doi":"10.1016/j.jss.2024.11.038","DOIUrl":"10.1016/j.jss.2024.11.038","url":null,"abstract":"<p><strong>Introduction: </strong>Abdominal and perineal repairs for rectal prolapse are offered to patients based on surgeon assessment of risk. Interpretations of risk can vary. We sought to understand how the preoperative Risk Analysis Index (RAI) score, a validated measure of frailty, aligned with our existing decision-making process for rectal prolapse repair.</p><p><strong>Methods: </strong>Rectal prolapse repair cases were recorded in an Institutional Review Board approved registry from 2017 to 2022. Abdominal and perineal operations were determined based on an experienced surgeon's recommendation. The preoperative RAI was collected; a score≥30 indicates significant frailty. Preoperative and postoperative characteristics were compared using t-tests and Fisher's exact tests.</p><p><strong>Results: </strong>About 130 patients underwent abdominal repairs and 51 underwent perineal repairs. Perineal patients were more often frail (abdominal: 9 [7%] versus perineal: 21 [41%], P < 0.001) and had a higher rate of cardiac comorbidities (abdominal: 42 [32%] versus perineal: 35 [69%], P < 0.001). A similar share of patients were undergoing repair for recurrent prolapse (abdominal: n = 29 [22%] versus perineal: n = 11 [22%], P > 0.99). Perineal repair patients were more likely to need assistance with mobility (n = 24 [47%]) and live in a facility (n = 15 [29%]). Patients in both groups recovered well (complication rate abdominal: 28 [22%] versus 11 [22%], P > 0.99) and were satisfied with postoperative outcomes (Patient Global Impression of Change score abdominal: 6 [interquartile range: 6, 7] versus perineal: 6 [5, 7], P = 0.12). Recurrence rates were higher after perineal repair (abdominal: 12 [9%] versus perineal: 20 [39%], P < 0.001).</p><p><strong>Conclusions: </strong>Most abdominal repair patients were not frail, but many nonfrail patients underwent perineal operations based on surgeon perception of comorbidities. Using the RAI tool may provide an opportunity to guide decision-making around operative approach for rectal prolapse and overcome potential surgeon bias.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"331-336"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142903363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automobile-Pedestrian Injuries: Are Pedestrian Safety Features Associated With Injury Severity? 汽车-行人伤害:行人安全设施与伤害严重程度有关吗?
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-13 DOI: 10.1016/j.jss.2024.11.011
Rebecca Minas-Alexander, Essam Hashem, Amber Jones, Matthew Hannon

Introduction: Automobile-pedestrian (AP) crashes can cause severe injuries and are increasing in frequency. We sought to determine factors contributing to severe injuries.

Methods: Patients ≥15 y with AP injuries admitted from January 1, 2020, through December 31, 2022, comprised the study population. Demographic data, injury severity score (ISS), and abbreviated injury scale (AIS) were obtained from the trauma registry. An electronic medical record review collected location, time and description of the incident, and substance use. Locations were grouped into multilane, high speed (>40 mph) streets, residential streets, and off-road. Pedestrian safety features were assessed using Google Street View. Each location census tract Area Deprivation Index was determined. Logistic regression was used to determine if safety features predicted increasing ISS or AIS.

Results: There were 426 patients. The mean ISS was 13.3. AP patients struck with a sidewalk present had a higher ISS (P = 0.03) and higher AIS head or neck (P = 0.01). Those struck on a street with <6 lanes had a lower ISS (P = 0.035). AP victims under the influence of a substance had higher ISS (P = 0.035) and AIS external (P = 0.049). More AP accidents occurred between 18:00-23:59 (43.8%). Most AP fatalities occurred between 18:00-5:59 (76%). Most AP injuries, 94.06% (P = 0.0), occurred in areas with an Area Deprivation Index of 9 or 10.

Conclusions: More severe AP injuries occurred along multilane roads with high-speed traffic and with a sidewalk. Injuries and fatalities more commonly occurred at night. Pedestrians using substances suffered more severe injuries. Most AP injuries occurred in socioeconomically disadvantaged areas.

导言:汽车与行人(AP)碰撞可造成严重伤害,且发生频率越来越高。我们试图确定导致严重伤害的因素:研究对象包括 2020 年 1 月 1 日至 2022 年 12 月 31 日期间收治的≥15 岁的车祸受伤患者。人口统计学数据、损伤严重程度评分(ISS)和简易损伤量表(AIS)均来自创伤登记处。电子病历审查收集了地点、时间、事故描述和药物使用情况。地点分为多车道、高速(大于 40 英里/小时)街道、住宅街道和非道路。行人安全特征通过谷歌街景进行评估。确定了每个地点人口普查区的地区贫困指数。采用逻辑回归法确定安全特征是否能预测 ISS 或 AIS 的增加:共有 426 名患者。平均 ISS 为 13.3。在人行道上被撞的 AP 患者 ISS 较高(P = 0.03),头部或颈部 AIS 较高(P = 0.01)。而在有结论的街道上被撞的 AP 患者的 ISS 值更高,AIS 头部或颈部更高(P = 0.01):在车速较快、有人行道的多车道道路上发生的急性颅脑损伤更为严重。伤亡事故多发生在夜间。使用药物的行人受伤更严重。大多数 AP 伤害发生在社会经济条件较差的地区。
{"title":"Automobile-Pedestrian Injuries: Are Pedestrian Safety Features Associated With Injury Severity?","authors":"Rebecca Minas-Alexander, Essam Hashem, Amber Jones, Matthew Hannon","doi":"10.1016/j.jss.2024.11.011","DOIUrl":"10.1016/j.jss.2024.11.011","url":null,"abstract":"<p><strong>Introduction: </strong>Automobile-pedestrian (AP) crashes can cause severe injuries and are increasing in frequency. We sought to determine factors contributing to severe injuries.</p><p><strong>Methods: </strong>Patients ≥15 y with AP injuries admitted from January 1, 2020, through December 31, 2022, comprised the study population. Demographic data, injury severity score (ISS), and abbreviated injury scale (AIS) were obtained from the trauma registry. An electronic medical record review collected location, time and description of the incident, and substance use. Locations were grouped into multilane, high speed (>40 mph) streets, residential streets, and off-road. Pedestrian safety features were assessed using Google Street View. Each location census tract Area Deprivation Index was determined. Logistic regression was used to determine if safety features predicted increasing ISS or AIS.</p><p><strong>Results: </strong>There were 426 patients. The mean ISS was 13.3. AP patients struck with a sidewalk present had a higher ISS (P = 0.03) and higher AIS head or neck (P = 0.01). Those struck on a street with <6 lanes had a lower ISS (P = 0.035). AP victims under the influence of a substance had higher ISS (P = 0.035) and AIS external (P = 0.049). More AP accidents occurred between 18:00-23:59 (43.8%). Most AP fatalities occurred between 18:00-5:59 (76%). Most AP injuries, 94.06% (P = 0.0), occurred in areas with an Area Deprivation Index of 9 or 10.</p><p><strong>Conclusions: </strong>More severe AP injuries occurred along multilane roads with high-speed traffic and with a sidewalk. Injuries and fatalities more commonly occurred at night. Pedestrians using substances suffered more severe injuries. Most AP injuries occurred in socioeconomically disadvantaged areas.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"126-130"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142823747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex-Related Outcomes in Asymptomatic Carotid Artery Stenosis Undergoing Carotid Endarterectomy. 无症状颈动脉狭窄行颈动脉内膜切除术的性别相关结局。
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-23 DOI: 10.1016/j.jss.2024.11.005
Elena Giacomelli, Walter Dorigo, Francesca Sibaldi, Rossella Di Domenico, Mascia Nesi, Aaron Thomas Fargion, Sara Speziali, Raffaele Pulli

Introduction: This study aims to retrospectively analyze the perioperative and long-term outcomes of carotid endarterectomy (CEA) performed in asymptomatic patients, stratifying the results by sex.

Methods: Data on CEAs performed from January 2009 to December 2020 at our institution were collected. A neurologic evaluation was conducted 30 d after surgery to assess the occurrence of neurological events. Instrumental evaluations using Doppler ultrasound were performed within the first 3 mo, at 12 mo, and annually thereafter. The primary endpoints were perioperative mortality, major neurological events, and major complications. Secondary endpoints included long-term overall survival, stroke-free survival, absence of neurological symptoms, and absence of significant (>70%) restenosis.

Results: Two thousand one hundred ninety-four CEAs were performed in asymptomatic patients, with 758 females and 1436 males. There were no differences in perioperative outcomes between the two groups. In the multivariate analysis, female sex was found to be a protective factor for the risk of 30-d stroke (hazard ratio: 0.2; 95% confidence interval: 0.04-0.9; P = 0.05). At a median follow-up of 24 mo, the estimated 10-y overall and stroke-free survival rates were 77.6% in males versus 62.7% in females, P = 0.2 and 70% in males versus 61% in females, P = 0.1, respectively. Also the rates of significant restenosis did not differ between males and females (82.2% versus 87.7%, P = 0.5).

Conclusions: This study suggests that female sex, by itself, does not represent a risk factor for adverse outcomes after carotid surgery and it appears to be protective in the first 30 d following surgery.

简介:本研究旨在回顾性分析无症状患者行颈动脉内膜切除术(CEA)的围手术期和远期预后,并按性别对结果进行分层。方法:收集2009年1月至2020年12月在我院进行的cea数据。术后30 d进行神经学评估,评估神经事件的发生情况。在前3个月、12个月和此后每年使用多普勒超声进行仪器评估。主要终点是围手术期死亡率、主要神经事件和主要并发症。次要终点包括长期总生存期、无卒中生存期、无神经系统症状、无明显再狭窄(约70%)。结果:无症状患者共行cea 2494例,其中女性758例,男性1436例。两组围手术期预后无差异。在多因素分析中,女性性别被发现是30天卒中风险的保护因素(危险比:0.2;95%置信区间:0.04-0.9;p = 0.05)。在中位随访24个月时,估计10年总生存率和无卒中生存率男性为77.6%,女性为62.7%,P = 0.2;男性为70%,女性为61%,P = 0.1。男性和女性的再狭窄发生率也无显著差异(82.2%对87.7%,P = 0.5)。结论:本研究表明,女性性别本身并不代表颈动脉手术后不良后果的危险因素,而且在手术后的前30天似乎具有保护作用。
{"title":"Sex-Related Outcomes in Asymptomatic Carotid Artery Stenosis Undergoing Carotid Endarterectomy.","authors":"Elena Giacomelli, Walter Dorigo, Francesca Sibaldi, Rossella Di Domenico, Mascia Nesi, Aaron Thomas Fargion, Sara Speziali, Raffaele Pulli","doi":"10.1016/j.jss.2024.11.005","DOIUrl":"10.1016/j.jss.2024.11.005","url":null,"abstract":"<p><strong>Introduction: </strong>This study aims to retrospectively analyze the perioperative and long-term outcomes of carotid endarterectomy (CEA) performed in asymptomatic patients, stratifying the results by sex.</p><p><strong>Methods: </strong>Data on CEAs performed from January 2009 to December 2020 at our institution were collected. A neurologic evaluation was conducted 30 d after surgery to assess the occurrence of neurological events. Instrumental evaluations using Doppler ultrasound were performed within the first 3 mo, at 12 mo, and annually thereafter. The primary endpoints were perioperative mortality, major neurological events, and major complications. Secondary endpoints included long-term overall survival, stroke-free survival, absence of neurological symptoms, and absence of significant (>70%) restenosis.</p><p><strong>Results: </strong>Two thousand one hundred ninety-four CEAs were performed in asymptomatic patients, with 758 females and 1436 males. There were no differences in perioperative outcomes between the two groups. In the multivariate analysis, female sex was found to be a protective factor for the risk of 30-d stroke (hazard ratio: 0.2; 95% confidence interval: 0.04-0.9; P = 0.05). At a median follow-up of 24 mo, the estimated 10-y overall and stroke-free survival rates were 77.6% in males versus 62.7% in females, P = 0.2 and 70% in males versus 61% in females, P = 0.1, respectively. Also the rates of significant restenosis did not differ between males and females (82.2% versus 87.7%, P = 0.5).</p><p><strong>Conclusions: </strong>This study suggests that female sex, by itself, does not represent a risk factor for adverse outcomes after carotid surgery and it appears to be protective in the first 30 d following surgery.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"204-213"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142885847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adventitial Injection of Hyaluronic Acid/Sodium Alginate Hydrogel Loaded With IL-33 Antibody Decreases Neointimal Hyperplasia. 体外注射负载IL-33抗体的HA/SA水凝胶可减少新生内膜增生。
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-11 DOI: 10.1016/j.jss.2024.11.017
Pengfei Shi, Peng Sun, Chunyang Lou, Jianbang Fang, Liwei Zhang, Boao Xie, Cong Zhang

Introduction: Neointimal hyperplasia is one of the persistent complications after vascular interventions, and is the major cause of treatment failure. Interleukin-33 (IL-33) emerges as a crucial factor in many biological processes and plays an important role in vascular diseases. Adventitial injection is catching attention for its effectiveness and fewer side effects. We hypothesize that targeting IL-33 by adventitial injection can be a therapeutic method to inhibit neointimal hyperplasia.

Method: IL-33 expression was examined in human vein graft. The hydrogel was fabricated by the interaction of hyaluronic acid, sodium alginate, and CaCO3; and phosphate buffered saline (PBS) or IL-33 antibody or recombinant IL-33 was mixed within the hydrogel uniformly. A rat aortic wire injury-induced neointimal hyperplasia model was developed; rats were divided into three groups and received an adventitial injection of a hydrogel loaded with PBS or IL-33 antibody or recombinant IL-33 after wire injury. Tissues were harvested at day 21 and analyzed by histology and immunohistochemical staining. Hydrogel loaded with PBS, IL-33 antibody, or IL-33 was also used in a mouse carotid artery ligation neointimal hyperplasia model.

Result: There was a high expression of IL-33 in human vein graft neointima. Hydrogel can be successfully injected into the aortic wall and is encapsulated by the adventitia. The hydrogel could be seen beneath the adventitia after adventitial injection and was partly degraded at day 21. There was a significantly thinner neointimal thickness and less proliferation and inflammation in the IL-33 antibody group compared to the control group. On the contrary, the IL-33 group has a thicker neointima, increased proliferation, and inflammation. The mouse carotid artery ligation model showed similar results.

Conclusions: IL-33 plays a role in arterial neointimal hyperplasia in both human and rodent models; adventitial injection of hydrogel loaded with IL-33 antibody can effectively decrease neointimal thickness. Neutralizing IL-33 by IL-33 antibody may be a potential therapeutic method to inhibit intimal hyperplasia after vascular interventions.

血管内膜增生是血管介入治疗后的持续性并发症之一,是导致治疗失败的主要原因。白细胞介素-33 (Interleukin-33, IL-33)在许多生物过程中起着至关重要的作用,在血管疾病中起着重要作用。体外注射因其疗效好、副作用小而备受关注。我们假设通过外膜注射靶向IL-33可能是一种抑制内膜增生的治疗方法。方法:检测人静脉移植组织中IL-33的表达。通过透明质酸、海藻酸钠和碳酸钙相互作用制备水凝胶;与磷酸盐缓冲盐水(PBS)或IL-33抗体或重组IL-33在水凝胶内均匀混合。建立大鼠主动脉丝损伤性内膜增生模型;将大鼠分为三组,在钢丝损伤后分别接受PBS或IL-33抗体或重组IL-33水凝胶的体外注射。第21天收获组织,进行组织学和免疫组织化学染色分析。在小鼠颈动脉结扎新生内膜增生模型中也使用了负载PBS、IL-33抗体或IL-33的水凝胶。结果:IL-33在人静脉移植新生内膜中高表达。水凝胶可以成功地注入主动脉壁,并被外膜包裹。外膜注射后,水凝胶在外膜下可见,在第21天部分降解。与对照组相比,IL-33抗体组新生内膜厚度明显变薄,增殖和炎症明显减少。相反,IL-33组新生内膜增厚,增殖增加,炎症增加。小鼠颈动脉结扎模型显示了类似的结果。结论:IL-33在人和啮齿类动物动脉内膜增生中均起一定作用;体外注射IL-33抗体水凝胶可有效降低内膜厚度。用IL-33抗体中和IL-33可能是抑制血管干预后内膜增生的潜在治疗方法。
{"title":"Adventitial Injection of Hyaluronic Acid/Sodium Alginate Hydrogel Loaded With IL-33 Antibody Decreases Neointimal Hyperplasia.","authors":"Pengfei Shi, Peng Sun, Chunyang Lou, Jianbang Fang, Liwei Zhang, Boao Xie, Cong Zhang","doi":"10.1016/j.jss.2024.11.017","DOIUrl":"10.1016/j.jss.2024.11.017","url":null,"abstract":"<p><strong>Introduction: </strong>Neointimal hyperplasia is one of the persistent complications after vascular interventions, and is the major cause of treatment failure. Interleukin-33 (IL-33) emerges as a crucial factor in many biological processes and plays an important role in vascular diseases. Adventitial injection is catching attention for its effectiveness and fewer side effects. We hypothesize that targeting IL-33 by adventitial injection can be a therapeutic method to inhibit neointimal hyperplasia.</p><p><strong>Method: </strong>IL-33 expression was examined in human vein graft. The hydrogel was fabricated by the interaction of hyaluronic acid, sodium alginate, and CaCO<sub>3</sub>; and phosphate buffered saline (PBS) or IL-33 antibody or recombinant IL-33 was mixed within the hydrogel uniformly. A rat aortic wire injury-induced neointimal hyperplasia model was developed; rats were divided into three groups and received an adventitial injection of a hydrogel loaded with PBS or IL-33 antibody or recombinant IL-33 after wire injury. Tissues were harvested at day 21 and analyzed by histology and immunohistochemical staining. Hydrogel loaded with PBS, IL-33 antibody, or IL-33 was also used in a mouse carotid artery ligation neointimal hyperplasia model.</p><p><strong>Result: </strong>There was a high expression of IL-33 in human vein graft neointima. Hydrogel can be successfully injected into the aortic wall and is encapsulated by the adventitia. The hydrogel could be seen beneath the adventitia after adventitial injection and was partly degraded at day 21. There was a significantly thinner neointimal thickness and less proliferation and inflammation in the IL-33 antibody group compared to the control group. On the contrary, the IL-33 group has a thicker neointima, increased proliferation, and inflammation. The mouse carotid artery ligation model showed similar results.</p><p><strong>Conclusions: </strong>IL-33 plays a role in arterial neointimal hyperplasia in both human and rodent models; adventitial injection of hydrogel loaded with IL-33 antibody can effectively decrease neointimal thickness. Neutralizing IL-33 by IL-33 antibody may be a potential therapeutic method to inhibit intimal hyperplasia after vascular interventions.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"107-117"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regional Anesthesia and Surgical Volume in Children Undergoing Nuss Repair: A Multicenter Review. 接受 Nuss 修复术儿童的区域麻醉和手术量:多中心回顾
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-19 DOI: 10.1016/j.jss.2024.11.014
Dimitra Lotakis, Jack P Vernamonti, Tiffany N Wright, Kyle J Van Arendonk, Peter C Minneci, Charles M Leys, Matthew P Landman, Shawn D St Peter, Rebeccah L Brown, Grace Z Mak, Tsehay B Abebe, K Elizabeth Speck

Introduction: Regional anesthetic approach and surgical volume have been shown to outcomes in patients undergoing Nuss procedure for pectus excavatum. However, their independent relationship is not described. We investigated how regional anesthesia and surgical volume are associated with length of stay (LOS), postoperative opioid use, operating room utilization, and complications.

Methods: This is a 9-center retrospective review of patients ≤21 ys after Nuss procedure for pectus excavatum (2016-2020). High-volume centers and surgeons defined as the upper-quartile for annual procedures. Outcomes were compared with mixed effects linear/logistic regression models with random intercepts by institution as appropriate. A single-center unadjusted analysis was performed of erector spinae catheter (ESC) utilization (due to nonuniform use; high-volume only at 1-center).

Results: 780 patients were included. Significant variation existed in anesthetic approach and volume. Cryoablation was independently associated with shorter LOS (-2.1 d; 95% confidence interval [CI]: -2.6,-1.7) and lower postoperative opioid utilization (-120 morphine milligram equivalents, 95% CI: -181, -58.1) but increased surgical time (+45 min; 95% CI: 30.3, 59.8). Individual surgeon volume was associated with decreased LOS (-0.3 d; 95% CI: -0.5, -0.01), though high-volume centers had increased complications (odds ratio 2.2; 95% CI: 1.1, 4.2). There was no association between anesthetic approach and surgical complications. Within the single center utilizing ESCs (n = 138), a shorter LOS (2 versus 3 d, P < 0.01) was observed compared to those not receiving an ESC (n = 19).

Conclusions: Analgesic approaches varied significantly across institutions and limited our ability to directly compare cryoablation and ESCs. On multivariate analysis, cryoablation was associated with decreased LOS and postoperative opioid use, irrespective of center and surgeon volume. ESCs were similarly associated with improved outcomes. Rigorous prospective comparison of ESCs and cryoablation is warranted.

介绍:有研究表明,区域麻醉方法和手术量对接受努斯手术治疗胸大肌的患者的疗效有影响。然而,它们之间的独立关系尚未得到描述。我们研究了区域麻醉和手术量与住院时间(LOS)、术后阿片类药物使用、手术室使用和并发症的关系:这是一项由 9 个中心共同完成的回顾性研究,研究对象为接受努氏手术治疗后年龄小于 21 岁的患者(2016-2020 年)。高容量中心和外科医生被定义为年手术量的上四分位数。采用混合效应线性/逻辑回归模型对结果进行比较,并酌情按机构设置随机截距。对单个中心的直立肌导管(ESC)使用情况进行了未经调整的分析(由于使用不统一;高容量仅在一个中心):结果:共纳入 780 名患者。结果:共纳入 780 例患者,麻醉方法和手术量存在显著差异。低温消融术与较短的LOS(-2.1 d;95% 置信区间[CI]:-2.6,-1.7)和较低的术后阿片类药物使用量(-120吗啡毫克当量,95% CI:-181,-58.1)独立相关,但增加了手术时间(+45 min;95% CI:30.3,59.8)。单个外科医生的数量与住院时间的缩短有关(-0.3 d;95% CI:-0.5,-0.01),但数量多的中心并发症增加(几率比 2.2;95% CI:1.1,4.2)。麻醉方法与手术并发症之间没有关联。在使用ESC的单个中心(n = 138)中,LOS较短(2 d对3 d,P 结论:LOS较短(2 d对3 d,P 结论:LOS较短(2 d对3 d,P 结论:LOS较短(2 d)):不同机构的镇痛方法差异很大,这限制了我们直接比较冷冻消融术和 ESCs 的能力。在多变量分析中,冷冻消融与缩短住院时间和减少术后阿片类药物的使用有关,与中心和外科医生的数量无关。同样,电刀也能改善疗效。有必要对ESC和冷冻消融进行严格的前瞻性比较。
{"title":"Regional Anesthesia and Surgical Volume in Children Undergoing Nuss Repair: A Multicenter Review.","authors":"Dimitra Lotakis, Jack P Vernamonti, Tiffany N Wright, Kyle J Van Arendonk, Peter C Minneci, Charles M Leys, Matthew P Landman, Shawn D St Peter, Rebeccah L Brown, Grace Z Mak, Tsehay B Abebe, K Elizabeth Speck","doi":"10.1016/j.jss.2024.11.014","DOIUrl":"10.1016/j.jss.2024.11.014","url":null,"abstract":"<p><strong>Introduction: </strong>Regional anesthetic approach and surgical volume have been shown to outcomes in patients undergoing Nuss procedure for pectus excavatum. However, their independent relationship is not described. We investigated how regional anesthesia and surgical volume are associated with length of stay (LOS), postoperative opioid use, operating room utilization, and complications.</p><p><strong>Methods: </strong>This is a 9-center retrospective review of patients ≤21 ys after Nuss procedure for pectus excavatum (2016-2020). High-volume centers and surgeons defined as the upper-quartile for annual procedures. Outcomes were compared with mixed effects linear/logistic regression models with random intercepts by institution as appropriate. A single-center unadjusted analysis was performed of erector spinae catheter (ESC) utilization (due to nonuniform use; high-volume only at 1-center).</p><p><strong>Results: </strong>780 patients were included. Significant variation existed in anesthetic approach and volume. Cryoablation was independently associated with shorter LOS (-2.1 d; 95% confidence interval [CI]: -2.6,-1.7) and lower postoperative opioid utilization (-120 morphine milligram equivalents, 95% CI: -181, -58.1) but increased surgical time (+45 min; 95% CI: 30.3, 59.8). Individual surgeon volume was associated with decreased LOS (-0.3 d; 95% CI: -0.5, -0.01), though high-volume centers had increased complications (odds ratio 2.2; 95% CI: 1.1, 4.2). There was no association between anesthetic approach and surgical complications. Within the single center utilizing ESCs (n = 138), a shorter LOS (2 versus 3 d, P < 0.01) was observed compared to those not receiving an ESC (n = 19).</p><p><strong>Conclusions: </strong>Analgesic approaches varied significantly across institutions and limited our ability to directly compare cryoablation and ESCs. On multivariate analysis, cryoablation was associated with decreased LOS and postoperative opioid use, irrespective of center and surgeon volume. ESCs were similarly associated with improved outcomes. Rigorous prospective comparison of ESCs and cryoablation is warranted.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"190-196"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142869420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncologic Efficacy of Robotic Compared to Open Total Pancreatectomy for Pancreatic Cancer. 机器人与开放式全胰腺切除术治疗胰腺癌的肿瘤疗效比较。
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-03 DOI: 10.1016/j.jss.2024.10.043
Jordan McKean, Austin Parrish, Doga Kahramangil Baytar, Alessandro Paniccia, Steven Hughes, Ibrahim Nassour

Introduction: The use of robotic surgery for pancreatic cancer resections is increasing over time. There are multiple studies comparing this approach to open surgery, specifically for Whipple and distal pancreatectomies. But there are limited data on its feasibility and oncologic efficacy in patients requiring total pancreatectomy.

Methods: This is a retrospective study from the 2010 to 2019 National Cancer Database comparing the postoperative, pathological, and long-term oncologic outcomes between robotic total pancreatectomy (RTP) and open total pancreatectomy (OTP) for pancreatic adenocarcinoma.

Results: One hundred eighty-eight (5%) RTP and 3447 (95%) OTP patients were identified. The number of RTP increased from four in 2010 to 32 in 2019. There were no major differences in patient demographics and treatment characteristics, except that RTP patients were more likely to be performed at nonacademic centers and less likely to get radiation. After adjustment, there was similar yield of examined lymph nodes, rate of positive margin, 90-d mortality and receipt of adjuvant therapy between both groups. RTP was associated with a statistically significant shorter length of stay than OTP (9 versus 11 d respectively, P value <0.001). There was no difference in median overall survival between RTP and OTP (22.3 mo versus 23.3 mo, P value 0.688). The 1-, 3-, and 5-y overall survival rates for RTP were 78%, 31%, and 34% and those for OTP were 75%, 38%, and 30%, respectively. After adjustment, the use of robotic surgery was associated with similar overall survival to the open approach (hazard ratio 0.939, 95% confidence interval 0.760-1.161).

Conclusions: RTP is associated with similar short- and long-term mortality without sacrificing oncologic outcomes including adequate lymphadenectomy and adjuvant chemotherapy receipt with the advantage of shorter length of stay.

随着时间的推移,机器人手术在胰腺癌切除术中的应用越来越多。有多项研究比较了这种方法与开放手术,特别是对于惠普尔和远端胰腺切除术。但在需要全胰切除术的患者中,其可行性和肿瘤学疗效的数据有限。方法:这是一项来自2010年至2019年国家癌症数据库的回顾性研究,比较机器人全胰腺切除术(RTP)和开放式全胰腺切除术(OTP)治疗胰腺腺癌的术后、病理和长期肿瘤学结果。结果:共发现RTP患者188例(5%),OTP患者3447例(95%)。RTP的数量从2010年的4个增加到2019年的32个。除了RTP患者更有可能在非学术中心接受治疗,接受放射治疗的可能性更小之外,患者人口统计学和治疗特征没有重大差异。调整后,两组患者的淋巴结检查率、阳性切缘率、90 d死亡率和接受辅助治疗的情况相似。与OTP相比,RTP与更短的住院时间相关(分别为9天和11天),P值结论:RTP与相似的短期和长期死亡率相关,而不牺牲肿瘤预后,包括充分的淋巴结切除术和辅助化疗接受,具有更短住院时间的优势。
{"title":"Oncologic Efficacy of Robotic Compared to Open Total Pancreatectomy for Pancreatic Cancer.","authors":"Jordan McKean, Austin Parrish, Doga Kahramangil Baytar, Alessandro Paniccia, Steven Hughes, Ibrahim Nassour","doi":"10.1016/j.jss.2024.10.043","DOIUrl":"10.1016/j.jss.2024.10.043","url":null,"abstract":"<p><strong>Introduction: </strong>The use of robotic surgery for pancreatic cancer resections is increasing over time. There are multiple studies comparing this approach to open surgery, specifically for Whipple and distal pancreatectomies. But there are limited data on its feasibility and oncologic efficacy in patients requiring total pancreatectomy.</p><p><strong>Methods: </strong>This is a retrospective study from the 2010 to 2019 National Cancer Database comparing the postoperative, pathological, and long-term oncologic outcomes between robotic total pancreatectomy (RTP) and open total pancreatectomy (OTP) for pancreatic adenocarcinoma.</p><p><strong>Results: </strong>One hundred eighty-eight (5%) RTP and 3447 (95%) OTP patients were identified. The number of RTP increased from four in 2010 to 32 in 2019. There were no major differences in patient demographics and treatment characteristics, except that RTP patients were more likely to be performed at nonacademic centers and less likely to get radiation. After adjustment, there was similar yield of examined lymph nodes, rate of positive margin, 90-d mortality and receipt of adjuvant therapy between both groups. RTP was associated with a statistically significant shorter length of stay than OTP (9 versus 11 d respectively, P value <0.001). There was no difference in median overall survival between RTP and OTP (22.3 mo versus 23.3 mo, P value 0.688). The 1-, 3-, and 5-y overall survival rates for RTP were 78%, 31%, and 34% and those for OTP were 75%, 38%, and 30%, respectively. After adjustment, the use of robotic surgery was associated with similar overall survival to the open approach (hazard ratio 0.939, 95% confidence interval 0.760-1.161).</p><p><strong>Conclusions: </strong>RTP is associated with similar short- and long-term mortality without sacrificing oncologic outcomes including adequate lymphadenectomy and adjuvant chemotherapy receipt with the advantage of shorter length of stay.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"19-25"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142780073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardization of Narcotic Prescriptions in Minimally Invasive General Surgery Procedures. 微创普外科麻醉处方规范化研究。
IF 1.8 3区 医学 Q2 SURGERY Pub Date : 2025-01-01 Epub Date: 2024-12-09 DOI: 10.1016/j.jss.2024.10.045
Astrid Leon, Justin Robbins, Ashley Hughes, Oumou Fofana, Corinna Crayton, Priti P Parikh, Timothy Crawford, Samantha Shugar, Casey Walk, Michelle DeGroat, Randy Woods

Introduction: The opioid crisis is a major public health issue, and postoperative opioids play a unique role. Many institutions have implemented standardized protocols to decrease excess opioids available. The objective of this study was to establish a standardized pain protocol for common surgical procedures and assess postoperative pain control.

Methods: This is a prospective observational study based on the Michigan Opioid Prescribing Engagement Network network guidelines which provides prescription recommendations for surgical procedures. We evaluated all laparoscopic/robotic cholecystectomy, appendectomy, and all herniorrhaphies. Patients were prescribed a predetermined number of narcotics by procedure as part of a multimodal pain regimen. A survey was conducted within 14 d postoperatively to assess pain control and narcotic utilization.

Results: A total of 442 patients were included from July 1, 2022 to October 28, 2022. Survey response was 40% (178/442) with 56% (249/442) prescribed per protocol. Fewer patients prescribed per protocol required refills, 9.6% (24/249) compared to 18.1% (35/193) (P = 0.007) without protocol. Patients reported taking significantly fewer narcotics with the protocol versus without (median = 5.0 versus 10.0, P < 0.001). The median number of narcotics taken were 5.5 for appendectomy, 7.0 for cholecystectomy, and 9.0 for herniorrhaphy. There was no difference in pain control when comparing patients with and without protocol (91.1% versus 90.5%, P = 1.0).

Conclusions: This study demonstrated that postoperative opioid prescriptions can be decreased by implementing a standardized protocol incorporating a multimodal regimen while adequately controlling pain following surgery.

阿片类药物危机是一个重大的公共卫生问题,术后阿片类药物发挥着独特的作用。许多机构已实施标准化方案,以减少可用的过量阿片类药物。本研究的目的是为常见的外科手术建立一个标准化的疼痛方案,并评估术后疼痛控制。方法:这是一项基于密歇根阿片类药物处方参与网络网络指南的前瞻性观察研究,该指南为外科手术提供处方建议。我们评估了所有腹腔镜/机器人胆囊切除术、阑尾切除术和所有疝修补术。作为多模式疼痛治疗方案的一部分,患者通过手术处方预定数量的麻醉剂。术后14 d内进行调查,评估疼痛控制和麻醉使用情况。结果:2022年7月1日至2022年10月28日共纳入442例患者。调查应答率为40%(178/442),每个方案规定了56%(249/442)。按方案就诊的患者需要重新就诊的较少,为9.6%(24/249),而无方案的患者为18.1% (35/193)(P = 0.007)。患者报告说,与未使用麻醉药物相比,使用麻醉药物的患者明显减少(中位数= 5.0 vs 10.0, P)。结论:本研究表明,在充分控制手术后疼痛的同时,通过实施一种包含多模式方案的标准化方案,可以减少术后阿片类药物处方。
{"title":"Standardization of Narcotic Prescriptions in Minimally Invasive General Surgery Procedures.","authors":"Astrid Leon, Justin Robbins, Ashley Hughes, Oumou Fofana, Corinna Crayton, Priti P Parikh, Timothy Crawford, Samantha Shugar, Casey Walk, Michelle DeGroat, Randy Woods","doi":"10.1016/j.jss.2024.10.045","DOIUrl":"10.1016/j.jss.2024.10.045","url":null,"abstract":"<p><strong>Introduction: </strong>The opioid crisis is a major public health issue, and postoperative opioids play a unique role. Many institutions have implemented standardized protocols to decrease excess opioids available. The objective of this study was to establish a standardized pain protocol for common surgical procedures and assess postoperative pain control.</p><p><strong>Methods: </strong>This is a prospective observational study based on the Michigan Opioid Prescribing Engagement Network network guidelines which provides prescription recommendations for surgical procedures. We evaluated all laparoscopic/robotic cholecystectomy, appendectomy, and all herniorrhaphies. Patients were prescribed a predetermined number of narcotics by procedure as part of a multimodal pain regimen. A survey was conducted within 14 d postoperatively to assess pain control and narcotic utilization.</p><p><strong>Results: </strong>A total of 442 patients were included from July 1, 2022 to October 28, 2022. Survey response was 40% (178/442) with 56% (249/442) prescribed per protocol. Fewer patients prescribed per protocol required refills, 9.6% (24/249) compared to 18.1% (35/193) (P = 0.007) without protocol. Patients reported taking significantly fewer narcotics with the protocol versus without (median = 5.0 versus 10.0, P < 0.001). The median number of narcotics taken were 5.5 for appendectomy, 7.0 for cholecystectomy, and 9.0 for herniorrhaphy. There was no difference in pain control when comparing patients with and without protocol (91.1% versus 90.5%, P = 1.0).</p><p><strong>Conclusions: </strong>This study demonstrated that postoperative opioid prescriptions can be decreased by implementing a standardized protocol incorporating a multimodal regimen while adequately controlling pain following surgery.</p>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"305 ","pages":"80-84"},"PeriodicalIF":1.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Surgical Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1